Literature DB >> 18987263

Potential mechanisms of adverse outcomes in trials of anemia correction with erythropoietin in chronic kidney disease.

Nosratola D Vaziri1, Xin J Zhou.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18987263     DOI： 10.1093/ndt/gfn601

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  31 in total

Review 1.  Intravenous iron in heart failure: beyond targeting anemia.

Authors:  Donald S Silverberg; Adrian Iaina; Doron Schwartz; Dov Wexler
Journal:  Curr Heart Fail Rep       Date:  2011-03

Review 2.  Therapeutic targeting of the HIF oxygen-sensing pathway: Lessons learned from clinical studies.

Authors:  Volker H Haase
Journal:  Exp Cell Res       Date:  2017-05-05       Impact factor: 3.905

3.  Clinical use of erythropoietin in chronic kidney disease: outcomes and future prospects.

Authors:  S T Provatopoulou; P N Ziroyiannis
Journal:  Hippokratia       Date:  2011-04       Impact factor: 0.471

Review 4.  Iron overdose: a contributor to adverse outcomes in randomized trials of anemia correction in CKD.

Authors:  Peter Van Buren; Ruben L Velez; Nosratola D Vaziri; Xin J Zhou
Journal:  Int Urol Nephrol       Date:  2011-07-10       Impact factor: 2.370

Review 5.  Management of anemia with erythropoietic-stimulating agents in children with chronic kidney disease.

Authors:  Bradley A Warady; Douglas M Silverstein
Journal:  Pediatr Nephrol       Date:  2013-09-05       Impact factor: 3.714

6.  Distinct subpopulations of FOXD1 stroma-derived cells regulate renal erythropoietin.

Authors:  Hanako Kobayashi; Qingdu Liu; Thomas C Binns; Andres A Urrutia; Olena Davidoff; Pinelopi P Kapitsinou; Andrew S Pfaff; Hannes Olauson; Annika Wernerson; Agnes B Fogo; Guo-Hua Fong; Kenneth W Gross; Volker H Haase
Journal:  J Clin Invest       Date:  2016-04-18       Impact factor: 14.808

7.  Management of anemia in children receiving chronic peritoneal dialysis.

Authors:  Dagmara Borzych-Duzalka; Yelda Bilginer; Il Soo Ha; Mustafa Bak; Lesley Rees; Francisco Cano; Reyner Loza Munarriz; Annabelle Chua; Silvia Pesle; Sevinc Emre; Agnieszka Urzykowska; Lily Quiroz; Javier Darío Ruscasso; Colin White; Lars Pape; Virginia Ramela; Nikoleta Printza; Andrea Vogel; Dafina Kuzmanovska; Eva Simkova; Dirk E Müller-Wiefel; Anja Sander; Bradley A Warady; Franz Schaefer
Journal:  J Am Soc Nephrol       Date:  2013-03-07       Impact factor: 10.121

Review 8.  Targeting EPO and EPO receptor pathways in anemia and dysregulated erythropoiesis.

Authors:  Nicole Rainville; Edward Jachimowicz; Don M Wojchowski
Journal:  Expert Opin Ther Targets       Date:  2015-09-30       Impact factor: 6.902

9.  Hemoglobin level and risk of hospitalization and mortality in children on peritoneal dialysis.

Authors:  Erin K Dahlinghaus; Alicia M Neu; Meredith A Atkinson; Jeffrey J Fadrowski
Journal:  Pediatr Nephrol       Date:  2014-08-10       Impact factor: 3.714

Review 10.  Red cell transfusion in chronic kidney disease in the United States in the current era of erythropoiesis stimulating agents.

Authors:  Nicole Brenner; Anuhya Kommalapati; Muhammad Ahsan; Anirban Ganguli
Journal:  J Nephrol       Date:  2019-11-28       Impact factor: 3.902
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.